FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416012507> ?p ?o ?g. }

• W2416012507 abstract "Introduction There is evidence to suggest that Very Early Onset Inflammatory Bowel Disease (VEOIBD) runs a more aggressive course when compared to older children with inflammatory bowel disease and may not respond to conventional therapy. Aim To study outcomes and disease course in children with VEOIBD (6 years and under at the time of diagnosis) in the era of established biological therapy. Method A retrospective descriptive analysis was performed on patients with VEOIBD at the Queen’s Medical Centre, Nottingham. These children were identified using the database and corroborated by clinician recall and histopathology records. We then analysed the medical notes, documenting diagnosis, histology findings, growth parameters, immune work-up, clinical course and management. Results We identified 12 patients with VEOIBD diagnosed between March 2011 and December 2014. 7 were male (58%). The median age at diagnosis was 3 years 6 months. Of our cohort: 5 had indeterminate colitis, 4 had a phenotype of Crohn’s disease and 3 had a phenotype of ulcerative colitis. The median duration of follow up is 15.5 months (4 mo - 56 mo). Of particular interest 75% of this cohort were born to non-British born parents, possibly indicating that the aetiology of VEOIBD may be related to a rapidly changing microbiome interacting with the innate and adaptive immune system. 3 of the 12 patients were considered to have severe disease (all males), with one of these cases having proceeded to bone marrow transplant and two further cases currently being considered for bone marrow transplant. 9 children received methylprednisolone at diagnosis to induce remission often followed by weaning of oral steroids. 9 children received Azathioprine. 4 received infliximab, 1 of whom progressed onto Adalimumab and Sirolimus in combination. At latest follow-up 9 out of the 12 children were considered to be in remission. Conclusion We describe the clinical course of children with VEOIBD. Histopathological diagnosis into Crohn’s disease and UC is more difficult in this group and early work up for monogenic disease is recommended for planning individualised treatment. VEOIBD is a distinct and heterogeneous category of bowel inflammation, the incidence of which is rising and more likely to affect children born to recent immigrant families." @default.
• W2416012507 created "2016-06-24" @default.
• W2416012507 creator A5022205814 @default.
• W2416012507 creator A5025550096 @default.
• W2416012507 creator A5050459556 @default.
• W2416012507 creator A5073933181 @default.
• W2416012507 creator A5084062891 @default.
• W2416012507 date "2016-04-01" @default.
• W2416012507 modified "2023-09-24" @default.
• W2416012507 title "G52(P) Very early onset inflammatory bowel disease – a single centre experience" @default.
• W2416012507 doi "https://doi.org/10.1136/archdischild-2016-310863.49" @default.
• W2416012507 hasPublicationYear "2016" @default.
• W2416012507 type Work @default.
• W2416012507 sameAs 2416012507 @default.
• W2416012507 citedByCount "0" @default.
• W2416012507 crossrefType "journal-article" @default.
• W2416012507 hasAuthorship W2416012507A5022205814 @default.
• W2416012507 hasAuthorship W2416012507A5025550096 @default.
• W2416012507 hasAuthorship W2416012507A5050459556 @default.
• W2416012507 hasAuthorship W2416012507A5073933181 @default.
• W2416012507 hasAuthorship W2416012507A5084062891 @default.
• W2416012507 hasConcept C126322002 @default.
• W2416012507 hasConcept C137627325 @default.
• W2416012507 hasConcept C167135981 @default.
• W2416012507 hasConcept C187212893 @default.
• W2416012507 hasConcept C195910791 @default.
• W2416012507 hasConcept C2775862500 @default.
• W2416012507 hasConcept C2778260677 @default.
• W2416012507 hasConcept C2779134260 @default.
• W2416012507 hasConcept C2780479503 @default.
• W2416012507 hasConcept C71924100 @default.
• W2416012507 hasConcept C72563966 @default.
• W2416012507 hasConceptScore W2416012507C126322002 @default.
• W2416012507 hasConceptScore W2416012507C137627325 @default.
• W2416012507 hasConceptScore W2416012507C167135981 @default.
• W2416012507 hasConceptScore W2416012507C187212893 @default.
• W2416012507 hasConceptScore W2416012507C195910791 @default.
• W2416012507 hasConceptScore W2416012507C2775862500 @default.
• W2416012507 hasConceptScore W2416012507C2778260677 @default.
• W2416012507 hasConceptScore W2416012507C2779134260 @default.
• W2416012507 hasConceptScore W2416012507C2780479503 @default.
• W2416012507 hasConceptScore W2416012507C71924100 @default.
• W2416012507 hasConceptScore W2416012507C72563966 @default.
• W2416012507 hasLocation W24160125071 @default.
• W2416012507 hasOpenAccess W2416012507 @default.
• W2416012507 hasPrimaryLocation W24160125071 @default.
• W2416012507 hasRelatedWork W1522764866 @default.
• W2416012507 hasRelatedWork W1980597439 @default.
• W2416012507 hasRelatedWork W1997119251 @default.
• W2416012507 hasRelatedWork W2012480034 @default.
• W2416012507 hasRelatedWork W2034116236 @default.
• W2416012507 hasRelatedWork W2041374264 @default.
• W2416012507 hasRelatedWork W2184488625 @default.
• W2416012507 hasRelatedWork W2333033919 @default.
• W2416012507 hasRelatedWork W2416360111 @default.
• W2416012507 hasRelatedWork W2468536535 @default.
• W2416012507 hasRelatedWork W2512383183 @default.
• W2416012507 hasRelatedWork W2610408070 @default.
• W2416012507 hasRelatedWork W2793722121 @default.
• W2416012507 hasRelatedWork W2987269286 @default.
• W2416012507 hasRelatedWork W3020054026 @default.
• W2416012507 hasRelatedWork W3038601439 @default.
• W2416012507 hasRelatedWork W3040597767 @default.
• W2416012507 hasRelatedWork W3168346836 @default.
• W2416012507 hasRelatedWork W3185952236 @default.
• W2416012507 hasRelatedWork W6408203 @default.
• W2416012507 isParatext "false" @default.
• W2416012507 isRetracted "false" @default.
• W2416012507 magId "2416012507" @default.
• W2416012507 workType "article" @default.